Diversity of Secondary Metabolism in Aspergillus nidulans Clinical Isolates is a research paper published in mSphere (2020). On theSindex it has a DataRank of 1.4. It has been cited 63 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.624
From this paper's citation signal
Citation Network Contribution
0.757
From 30 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 35 citers.
European Union's Horizon 2020 Research and Innovation Programme
Grant: ERC-2016-724173
Sao Paulo Research Foundation
Grant: 2017/14159-2
HHS | National Institutes of Health
Grant: T32 ES007015
HHS | National Institutes of Health
Grant: R01AI065728
National Science Foundation
Grant: DEB-1442113
USDA | National Institute of Food and Agriculture
Grant: 2019-67012-29662
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2019/00631-7
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2017/19821-5
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2016/07870-9
Vanderbilt University
Grant: Discovery Grant
European Research Council
Grant: 724173
Reticulate evolution: patterns and impacts of non-vertical inheritance in eukaryotic genomes.
NIGMS NIH HHS
Grant: R01 GM112739
National Science Foundation
Grant: 1442113
DIMENSIONS: Collaborative Research: The Making of Biodiversity Across the Yeast Subphylum
National Institutes of Health
Grant: 5T32ES007015-35
Molecular & Environmental Toxicology Pre-& Postdoctoral Training Program
National Institutes of Health
Grant: 2R01AI065728-06A1
Decoding the pathogenic interactome of Aspergillus fumigatus
FWCI
4.60
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 1 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 2 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 2 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 3 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 3 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 4 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 4 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 5 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 5 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 6 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin
Additional file 6 of Screening and genetic engineering of marine-derived Aspergillus terreus for high-efficient production of lovastatin